Home
Vivanza Biosciences Ltd PE Ratio

Vivanza Biosciences Ltd
NSE: VIVANZABIOSCI
PE
Key Highlights
- The P/E Ratio of Vivanza Biosciences Ltd is 0 as of 22 Mar 9.00 AM .
- The P/E Ratio of Vivanza Biosciences Ltd changed from 687.4 on March 2021 to 48.5 on March 2024 . This represents a CAGR of -48.46% over 4 years.
- The Latest Trading Price of Vivanza Biosciences Ltd is ₹ 2.15 as of 21 Mar 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.1 in 2024.
Historical P/E Ratio of Vivanza Biosciences Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Vivanza Biosciences Ltd
Company Fundamentals for Vivanza Biosciences Ltd

Vivanza Biosciences Ltd
NSE: VIVANZABIOSCI
Share Price
Market Price of Vivanza Biosciences Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Mar 2025 | 2.15 |
20 Mar 2025 | 2.15 |
19 Mar 2025 | 2.11 |
18 Mar 2025 | 2.07 |
17 Mar 2025 | 2.11 |
13 Mar 2025 | 2.15 |
12 Mar 2025 | 2.19 |
11 Mar 2025 | 2.23 |
10 Mar 2025 | 2.27 |
07 Mar 2025 | 2.31 |
SWOT Analysis Of Vivanza Biosciences Ltd
BlinkX Score for Vivanza Biosciences Ltd
Asset Value vs Market Value of Vivanza Biosciences Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Vivanza Biosciences Ltd | 8.6 | - |
Sun Pharmaceuticals Industries Ltd | 428017 | 36.3 |
Divis Laboratories Ltd | 153854 | 74.4 |
Cipla Ltd | 123024 | 24.7 |
Torrent Pharmaceuticals Ltd | 109108 | 58.6 |
Dr Reddys Laboratories Ltd | 100076 | 18.6 |
Company | |
---|---|
Vivanza Biosciences Ltd | 8.6 |
Sun Pharmaceuticals Industries Ltd | 428017 |
Divis Laboratories Ltd | 153854 |
Cipla Ltd | 123024 |
Torrent Pharmaceuticals Ltd | 109108 |
Dr Reddys Laboratories Ltd | 100076 |
PE Ratio of Vivanza Biosciences Ltd Explained
₹8.6
Market cap
₹0
Earnings
0.0X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Vivanza Biosciences Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Vivanza Biosciences Ltd
Historical Revenue, EBITDA and Net Profit of Vivanza Biosciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Vivanza Biosciences Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Vivanza Biosciences Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Vivanza Biosciences Ltd
About Vivanza Biosciences Ltd
- Vivanza Biosciences Ltd (Previously known Ivee Injectaa Limited) was established in March, 1982 as a Private Limited Company and was converted into a Public Limited Company in May, 1992.
- Head quartered in Gujarat, India, the Company came into existence in April 2016 with the sole aim to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system. The Company is presently engaged in the business of Pharmaceutical Products and Pharma Products. However Competition in the industry is continuously increasing.
- New technology is being adopted and steps are taken to improve the manufacturing capacity of the Company.
- Further, the Company has also set its vision in global market to supply and execute turnkey pharmaceutical units. The company undertook an expansion-cum-diversification programme to increase its capacity from 18 lac pa to 54 lac pa.
Vivanza Biosciences Ltd News Hub
Vivanza Biosciences consolidated net profit declines 44.90% in the June 2024 quarter
Net profit of Vivanza Biosciences declined 44.90% to Rs 0.27 crore in the quarter ended June 2024 as
Read more
09 Aug 24
Vivanza Biosciences to announce Quarterly Result
Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 8 August 2024. P
Read more
03 Aug 24
Vivanza Biosciences to declare Quarterly Result
Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 17 October 2024.
Read more
11 Oct 24
Vivanza Biosciences consolidated net profit declines 92.31% in the September 2024 quarter
Net profit of Vivanza Biosciences declined 92.31% to Rs 0.02 crore in the quarter ended September 20
Read more
18 Oct 24